S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSEAMERICAN:BVX

Bovie Medical (BVX) Stock Price, News & Analysis

$6.48
+0.07 (+1.09%)
(As of 12/31/2018)
Today's Range
$6.35
$6.71
50-Day Range
N/A
52-Week Range
$2.28
$7.70
Volume
129,500 shs
Average Volume
136,878 shs
Market Capitalization
$215.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BVX stock logo

About Bovie Medical Stock (NYSEAMERICAN:BVX)

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

BVX Stock Price History

BVX Stock News Headlines

Bovie Medical earnings: here's what Wall Street expects
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
MEDICAL MYSTERIES
Bovie Medical (BVX) Looks Good: Stock Moves 9.1% Higher
See More Headlines
Receive BVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bovie Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2018
Today
4/19/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:BVX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$215.14 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Charles D. Goodwin
    President, Chief Executive Officer & Director
  • Matthew C. Hill
    Chief Financial & Accounting Officer
  • Shawn D. Roman
    Director-Research & Development
  • Kari Larson
    Senior Director-Clinical Affairs
  • Todd Hornsby
    Executive Vice President

BVX Stock Analysis - Frequently Asked Questions

How were Bovie Medical's earnings last quarter?

Bovie Medical Co. (NYSEAMERICAN:BVX) announced its earnings results on Thursday, November, 1st. The medical device company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.08. The medical device company had revenue of $3.67 million for the quarter, compared to analysts' expectations of $3.67 million. The company's quarterly revenue was up 38.5% compared to the same quarter last year. During the same period last year, the business earned ($0.09) EPS.

What other stocks do shareholders of Bovie Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), AbbVie (ABBV), ENGlobal (ENG), Airgain (AIRG), Liquidity Services (LQDT), A.H. Belo (AHC), AMAG Pharmaceuticals (AMAG), Antares Pharma (ATRS), Ceragon Networks (CRNT) and Genetic Technologies (GENE).

How do I buy shares of Bovie Medical?

Shares of BVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:BVX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners